AboutBusiness
HelpPrivacyTerms
SummaryLegal & StatusTimelineNetworkOwnership & ManagementShareholdersUltimate Beneficial OwnerGeographyFinancialsFinancial HealthDocuments
SummaryLegal & StatusTimelineNetworkOwnership & ManagementShareholdersUltimate Beneficial OwnerGeographyFinancialsFinancial HealthDocuments

PHARMACIE DU MARCHE

🇫🇷France•5484•Active
YoY profit / (loss) (2023 vs 2024)YoY profit / (loss)
-21.9%
Return on assets (net) (2024)Return on assets (net)
2.8%
CAGR profit / (loss) (2016–2024)CAGR profit / (loss)

Summary

Country🇫🇷France
StatusActive
Registration Number51370491600016
Founded13/07/2009
Address11 Pl Du Marche, Lezay, 79120

Legal & Status

Legal Form5484
StatusActive
Registration Date13/07/2009
Registry AuthorityINPI
Registered Capital100,000

Source: FR INPI · Last updated: 30/03/2026

Timeline (2 events)

11/02/2025

Emma Rougier (person)

Appointed as Officer

13/07/2009

Company incorporated

Incorporation date: 2009-07-13

Network

Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Network depth

Ownership & Management

Officers & directors

Emma Rougier

Officer

Appointed: 11/02/2025

—

Ownership Timeline

No ownership changes found

Shareholders

NameHoldingVotingSince
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Ultimate Beneficial Owner

NameOwnershipCountrySince
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Geography

Headquarters

11 Pl Du Marche

Lezay

79120

Financials

Key figures from annual accounts filings.

Convert to

2016

Profit / (loss): €71.0K

Key figures

Profit / (loss)

2016€70,956
2017€71,755
2018€90,854
2019€68,877
2020€70,760
2021€88,502
2022€103,428
2023€50,629
2024€39,541

Total assets

2016€1,383,263
2017€1,358,558
2018€1,432,992
2019€1,425,214
2020€1,447,295
2021€1,458,899
2022€1,495,070
2023€1,482,431
2024€1,432,179

Share Capital

2016€100,000
2017€100,000
2018€100,000
2019€100,000
2020€100,000
2021€100,000
2022€100,000
2023€100,000
2024€100,000
Metric201620172018201920202021202220232024
Profit / (loss)€70,956€71,755€90,854€68,877€70,760€88,502€103,428€50,629€39,541
Total assets€1,383,263€1,358,558€1,432,992€1,425,214€1,447,295€1,458,899€1,495,070€1,482,431€1,432,179
Share Capital€100,000€100,000€100,000€100,000€100,000€100,000€100,000€100,000€100,000

Documents

Document downloads are not available yet for French companies.

Comptes annuels

Accounts for the accounting period ending on: 30/06/2024

Filed: 25/04/2025

Document AI

Coming soon

Companexia Document AI

Ask questions about filings and extracts—our AI will read the documents and answer in context.

Formalité RNE — création 2009-07-13

11/02/2025

Comptes annuels

Accounts for the accounting period ending on: 30/06/2023

Filed: 18/03/2024

Comptes annuels

Accounts for the accounting period ending on: 30/06/2022

Filed: 26/06/2023

Comptes annuels

Accounts for the accounting period ending on: 30/06/2021

Filed: 13/04/2022

Comptes annuels

Accounts for the accounting period ending on: 30/06/2020

Filed: 01/02/2021

Comptes annuels

Accounts for the accounting period ending on: 30/06/2019

Filed: 16/03/2020

Comptes annuels

Accounts for the accounting period ending on: 30/06/2018

Filed: 25/06/2019

Comptes annuels

Accounts for the accounting period ending on: 30/06/2017

Filed: 04/04/2018

Showing 1–10 of 11

1 / 2

Browse more companies & persons

🇮🇪KILDALE LIMITED🇮🇪BRAMBURY LIMITED🇮🇪AVONMOUNT LIMITEDFARID BAYOUGHEVART ERICCHI PING TZENG
-7%
YoY total assets (2023 vs 2024)YoY total assets
-3.4%
CAGR total assets (2016–2024)CAGR total assets
+0.4%

Financial Health

Derived ratios from annual accounts. Values are omitted when data is missing or not meaningful.

Growth

YoY profit / (loss) (2016 vs 2017)
+1.1%
YoY total assets (2016 vs 2017)
-1.8%
YoY profit / (loss) (2017 vs 2018)
+26.6%
YoY total assets (2017 vs 2018)
+5.5%
YoY profit / (loss) (2018 vs 2019)
-24.2%
YoY total assets (2018 vs 2019)
-0.5%
YoY profit / (loss) (2019 vs 2020)
+2.7%
YoY total assets (2019 vs 2020)
+1.5%
YoY profit / (loss) (2020 vs 2021)
+25.1%
YoY total assets (2020 vs 2021)
+0.8%
YoY profit / (loss) (2021 vs 2022)
+16.9%
YoY total assets (2021 vs 2022)
+2.5%
YoY profit / (loss) (2022 vs 2023)
-51%
YoY total assets (2022 vs 2023)
-0.8%
YoY profit / (loss) (2023 vs 2024)
-21.9%
YoY total assets (2023 vs 2024)
-3.4%
CAGR profit / (loss) (2016–2024)
-7%
CAGR total assets (2016–2024)
+0.4%

Efficiency & returns

Return on assets (net) (2016)
5.1%
Return on assets (net) (2017)
5.3%
Return on assets (net) (2018)
6.3%
Return on assets (net) (2019)
4.8%
Return on assets (net) (2020)
4.9%
Return on assets (net) (2021)
6.1%
  1. Home
  2. –France
  3. –Lezay
  4. –PHARMACIE DU MARCHE
Return on assets (net) (2022)
6.9%
Return on assets (net) (2023)
3.4%
Return on assets (net) (2024)
2.8%